About Okami Medical
Okami Medical, Inc. is a privately-held medical device company with a mission to address the evolving needs of patients and physicians through the development of innovative, versatile, and intuitive devices for the occlusion of peripheral vessels. Okami designed the LOBO Vascular Occlusion System to allow physicians to access and rapidly occlude a wide range of vascular targets. The company was created in 2017 by Inceptus Medical, a medical device incubator. Okami is backed by members of the board of directors, U.S. Venture Partners (USVP) and medical device industry veterans.
Bob Rosenbluth, Ph.D., President & Co-Founder
Bob has an extensive background of leadership, innovation, and entrepreneurship in the medical device industry. Bob is one of the Co-founders of Inceptus Medical, a medical device incubator founded in 2011, and serves as Chairman, President and CEO. More recently, he was a founder of Inari Medical and currently serves as Chairman of the Board. Prior to Inceptus and Inari, Bob was a founder of Sequent Medical. Sequent was acquired by Terumo Medical Corporation for $380M. Before Sequent, Bob was a founder of MicroVention, serving as President and CEO since its inception in 1997 through 2002 and as Chairman of the Board from inception through 2006. MicroVention was acquired by Terumo in 2006. Prior to founding MicroVention, he founded Advanced Surgical Intervention and served in various business development and senior management positions at Medtronic, Pfizer, and Cardiothoracic Systems. He holds a B.S. in chemical engineering from Columbia University, an M.S. in chemical engineering, and a Ph.D. in mechanical engineering from UC Berkeley.
Brian Cox, Vice President & Co-Founder
Brian is a Principal and Co-founder of Inceptus Medical, a medical device incubator founded in 2011, and Co-founder and Vice President of Inari Medical. Prior to Inceptus and Inari, Brian was a founder of Sequent Medical where he served as Vice President and Chief Technical Officer. Sequent was acquired by Terumo Medical Corporation for $380M. Prior to Sequent, Brian was a founder of MicroVention which was acquired by Terumo in 2006. At MicroVention, Brian served as Vice President of Business and Technology Development. Prior to MicroVention, Brian was Engineering Manager at AneuRx, which was acquired by Medtronic in 1996. Prior to AneuRx, he held various managerial and technical positions with Advanced Surgical Intervention, Allergan Medical Optics, and Shiley/Pfizer. He earned a B.S. in mechanical engineering from Oregon State University and a M.B.A. from Pepperdine University. Brian is an inventor on over 60 issued U.S. and international patents.
Paul Lubock, Vice President & Co-Founder
Paul is a Principal and Co-founder of Inceptus Medical, a medical device incubator founded in 2011, and Co-founder and Vice President of Inari Medical. Prior to Inceptus and Inari, he was a co-founder of SenoRx, which was acquired by C.R. Bard in 2010 for $213M. He served as Chief Technical Officer from 1999 and Senior Vice President from April 2009 until his departure in 2011. Paul also served on the Board of Directors from 1998 to 2001 and served as Chief Operating Officer from 1998 to 1999. Prior to 1998, Paul was the Co-founder and a Principal at Abacus Design & Development, a medical product development company, and the founder of Laparomed, which was acquired by Advanced Surgical in 1994. Paul held various positions at Laparomed, including President, Vice President of Engineering and served on its Board of Directors. Previously he was Vice President of Engineering at Medstone and held engineering management roles at Shiley/Pfizer and Thoratec. Paul holds over 170 issued U.S. patents. He earned his B.A. in Applied Mechanics and Engineering Science from the University of California, San Diego and his M.S. in Mechanical Engineering from the University of California, Berkeley.